IRUS Total

Metabolically-defined body size phenotypes and risk of endometrial cancer in the European prospective investigation into cancer and nutrition (EPIC)

File Description SizeFormat 
1359.pdfPublished version266.09 kBAdobe PDFView/Open
Title: Metabolically-defined body size phenotypes and risk of endometrial cancer in the European prospective investigation into cancer and nutrition (EPIC)
Authors: Kliemann, N
Ould Ammar, R
Biessy, C
Gicquiau, A
Katzke, V
Kaaks, R
Tjoenneland, A
Olsen, A
Sánchez, M-J
Crous-Bou, M
Pasanisi, F
Tin Tin, S
Perez-Cornago, A
Aune, D
Christakoudi, S
Heath, AK
Colorado-Yohar, SM
Grioni, S
Skeie, G
Sartor, H
Idahl, A
Rylander, C
M. May, A
Weiderpass, E
Freisling, H
Playdon, MC
Rinaldi, S
Murphy, N
Huybrechts, I
Dossus, L
Gunter, MJ
Item Type: Journal Article
Abstract: Background: Obesity is a risk factor for endometrial cancer but whether metabolic dysfunction is associated with endometrial cancer independent of body size is not known. Methods: The association of metabolically-defined body size phenotypes with endometrial cancer risk was investigated in a nested case-control study (817 cases/ 817 controls) within the European Prospective Investigation into Cancer and Nutrition (EPIC). Concentrations of C-peptide were used to define metabolically healthy (MH; <1st tertile) and metabolically unhealthy (MU; >=1st tertile) status among the control participants. These metabolic health definitions were combined with normal weight (NW; Body Mass Index (BMI)<25kg/m2 or Waist Circumference (WC)<80cm or Waist-to-Hip Ratio (WHR)<0.8) and overweight (OW; BMI>=25kg/m2 or WC>=80cm or WHR>=0.8) status, generating four phenotype groups for each anthropometric measure: (1)MH/NW, (2)MH/OW (3)MU/NW and (4)MU/OW. Results: In a multivariable-adjusted conditional logistic regression model, compared with MH/NW individuals, endometrial cancer risk was higher among those classified as MU/NW (OR/WC=1.48; 95%CI 1.05-2.10 and OR/WHR=1.68; 95%CI 1.21-2.35) and MU/OW (OR/BMI=2.38, 95%CI 1.73-3.27; OR/WC=2.69, 95%CI 1.92-3.77 and OR/WHR=1.83, 95%CI 1.32-2.54). MH/OW individuals were also at increased endometrial cancer risk compared to MH/NW individuals (OR/WC=1.94, 95%CI 1.24-3.04). Conclusions: Women with metabolic dysfunction appear to have higher risk of endometrial cancer regardless of their body size. However, overweight status raises endometrial cancer risk even among women with lower insulin levels, suggesting that obesity-related pathways are relevant for the development of this cancer beyond insulin. Impact: Classifying women by metabolic health may be of greater utility in identifying those at higher risk for endometrial cancer than anthropometry per se.
Issue Date: 1-Jul-2022
Date of Acceptance: 13-Apr-2022
URI: http://hdl.handle.net/10044/1/96669
DOI: 10.1158/1055-9965.epi-22-0160
ISSN: 1055-9965
Publisher: American Association for Cancer Research
Start Page: 1359
End Page: 1367
Journal / Book Title: Cancer Epidemiology, Biomarkers and Prevention
Volume: 31
Issue: 7
Copyright Statement: © 2022 The Authors; Published by the American Association for Cancer Research. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs International 4.0 License.
Keywords: Epidemiology
11 Medical and Health Sciences
Publication Status: Published
Open Access location: https://doi.org/10.1158/1055-9965.EPI-22-0160
Online Publication Date: 2022-04-18
Appears in Collections:Faculty of Medicine
School of Public Health

This item is licensed under a Creative Commons License Creative Commons